Twist Bioscience Corp. Stock News

Gainers Satixfy Communications Ltd. (NYSE: SATX) shares gained 140.7% to settle at $31.80 on Tuesday. Tenax Therapeutics, Inc. (NASDAQ: TENX) jumped 45.7% to close at $0.1351 on Tuesday. Exagen Inc.

A negative report by a short-seller drove the biotech's shares downward.

A negative report by a short-seller drove the biotech's shares downward.

Gainers SenesTech, Inc. (NASDAQ: SNES) shares surged 91.7% to $0.2751. SenesTech reported a 1-for-20 reverse stock split. Pineapple Energy Inc. (NASDAQ: PEGY) shares jumped 45% to $3.41 after the com

U.S. stocks traded higher, with the Nasdaq gaining more than 200 points on Tuesday. Here are some big stocks recording losses in today’s session. AMMO, Inc. (NASDAQ: POWW) shares tumbled 26% to $2

Today, we're witnessing an example of how a short report can impact a stock. Reportedly, activist short seller Scorpion Capital just published a report about Twist Bioscience (NASDAQ: TWST ).

Shares of Twist Bioscience Corp. TWST, -3.48% plunged 18.7% in premarket trading on Tuesday after Scorpion Capital, an activist short seller, described the company as a "cash-burning inferno" and a "'

Palatin Technologies, Inc. (PTN) delivered earnings and revenue surprises of 35.82% and 8.75%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the

Twist Bioscience (TWST) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength dow

Twist Bioscience (TWST) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength dow

Immuneering Corporation (IMRX) delivered earnings and revenue surprises of -2.08% and 92.17%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the s

Aadi Bioscience, Inc. (AADI) delivered earnings and revenue surprises of 9.33% and 18.05%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stoc

Revance Therapeutics, Inc. (RVNC) delivered earnings and revenue surprises of -37.65% and 0.90%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for th

The biggest reason why Twist is currently valued at $1.9 billion is the potential to use their silicon DNA synthesis platform for the discovery of new drugs.

ARK Invest’s 13F portfolio value decreased from $16.91B to $14.35B this quarter. Click to see the firm's trades for Q3 2022.